Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment (Q73039702)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

mild cognitive impairment

1 reference

inferred from title

cognitive dysfunction

1 reference

7

K Blennow

1 reference

31 October 2019

6

B Winblad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

3

E Vanmechelen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

2

L Minthon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

N Andreasen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Vanderstichele

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Davidsson

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

5-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

1 reference

7 January 2021

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900617-5

7 January 2021

10.1016/S0304-3940(99)00617-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10505638%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference